← Insider Monitor
Candel Therapeutics, Inc. logo
CADL

Candel Therapeutics, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Candel Therapeutics is a clinical-stage biopharmaceutical company developing viral immunotherapies designed to destroy cancer cells and activate an immune response against tumors, with lead candidates in development for glioblastoma and other solid tumors.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Needham, MA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Tyagarajan SeshuChief Technology OfficerSell$84KAug 17, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for CADL.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable CADL activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.